IL7 and neoplasm: The in vitro assay of IFN-γ production may not be fully reflective of the in vivo capacity of T cells to mediate tumor regression because CD4+ T cells cultured with IL-2 plus IL-7 had only 2% IFN-γ positive cells despite equivalent in vivo anti-tumor efficacy.